Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study for Naltrexone on the Abuse Potential of Methylphenidate
Phase 1
Completed
- Conditions
- NaltrexoneMethylphenidate Abuse
- Interventions
- Drug: PlaceboDrug: Treatment Phase Sequence 4213Drug: Treatment Phase Sequence 2134Drug: Treatment Phase Sequence 1342Drug: Treatment Phase Sequence 3421
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Avekshan LLC
- Target Recruit Count
- 94
- Registration Number
- NCT03769064
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Inc., Overland Park, Kansas, United States
News
No news found